Cancer research building
Oregon Health & Science University’s (OHSU) Knight Cancer Institute built a new research building at South Waterfront district in south-west Portland, Oregon, US.
The facility will accommodate up to 650 scientists, physicians and administrators focusing on early cancer detection, computational biology, and immuno-oncology.
Construction of the facility commenced in June 2016 and was completed in September 2018.
Knight Cancer Institute and Immunovia announced collaboration in October 2015 to confirm, validate and commercialise blood tests for the early diagnosis of cancer. The institute also reached a collaboration agreement with Cancer Research UK in December 2015 to accelerate early cancer detection research.
The building’s design was aimed at bringing collaboration and interaction. It features shared spaces and wet and dry research laboratories, including small-group, informal workspaces to allow researchers to undertake reflective and privately focused work. The laboratories are designed to receive lighting and solar control.
The design also creates social opportunities, with a central kitchen, a lounge, and a casual seating area. The exterior balconies and rooftop terrace provide views of the Willamette River and the Cascade Mountains. The building also includes administrative offices and a car parking area.
The environmentally sustainable elements have been incorporated into the building with an aim to achieve LEED platinum certification.
The seven-storey research facility has a total floor space of 320,000ft², situated to the north of the collaborative life sciences building on the OHSU campus.
Research and wet lab spaces are featured from floors two to five, while the ground floor contains a 200-seat auditorium, meeting rooms, and a conference centre. It also includes spaces for street-level retail, a café, and other amenities.
Two floors of the building are used to house the Cancer Early Detection Advanced Research Centre. This provides multidisciplinary research teams with a collaborative environment to perform early detection research under the guidance of nanotechnology expert Sadik Esener.
A ground-breaking ceremony for the construction of Knight Cancer Institute’s research building was attended by Oregon State Governor Kate Brown, doctors, and cancer survivors in June 2016.
The construction crew used interactive 3D building information modelling (BIM).
Oregon’s State Legislature passed a bill to finance $200m for the project in 2014 as part of the $1bn Knight Cancer Challenge initiated by Phil Knight.
The research facility was built at a cost of $190m, $160m of which was funded by the Oregon State Legislature with the remaining provided by the OHSU Knight Cancer Institute.
The designs for the Knight Cancer Institute research building were provided by architect SRG Partnership.
The joint venture of McCarthy Building Companies and Andersen Construction (McCarthy/Andersen) secured the contract for the construction of the building.
Lonza announced the expansion of its bioconjugation facility at its Visp site in Switzerland in December 2020. The expansion will…
Thermo Fisher Scientific (Thermo Fisher) will establish a new pharmaceutical services facility for integrated biologics and sterile drug development and…
Lykan Bioscience opened a purpose-built SMART Manufacturing™ facility for developing cell-based therapies in Hopkinton, Massachusetts, US, in September 2020. The…
Merck announced the expansion of its high-potent active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) production capabilities and capacity at…